Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Rose C. Perri currently holds 975,478 shares of GENEREX BIOTECHNOLOGY CORP (GNBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rose C. Perri has been a net buyer of GNBT stock. They have purchased $28.5K and sold $13.6K worth of shares.
Rose C. Perri's most recent insider trade was on May 9, 2011, when they sold 15,000 shares at $0.23 per share.
Rose C. Perri serves as Executive at GENEREX BIOTECHNOLOGY CORP (GNBT). They have executed 9 insider transactions totaling $42.1K over their tenure at the company.
Rose C. Perri holds the position of Executive at GENEREX BIOTECHNOLOGY CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Rose C. Perri has shown a buying trading pattern, with $28.5K in total purchases and $13.6K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Rose C. Perri was on Oct 27, 2010, when they purchased $18.9K worth of GNBT shares. This transaction involved 54,000 shares at $0.35 per share.
Rose C. Perri currently owns 975,478 shares of GENEREX BIOTECHNOLOGY CORP (GNBT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Rose C. Perri's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Rose C. Perri has 9 Form 4 filings on record as an insider at GENEREX BIOTECHNOLOGY CORP.
Set alerts for Rose C. Perri and 40,000+ other insiders.